Stock analysts at StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a report issued on Thursday. The firm set a “hold” rating on the stock. Brooklyn ImmunoTherapeutics Stock Down 2.5 % Shares of BTX stock opened at $3.14 on Thursday. The stock has a market cap of $184.71 million, a […]